Drug intelligence / Profile preview

Drontal Plus Tasty

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

**Drontal Plus Tasty** is a veterinary oral combination anthelmintic developed by Bayer and now marketed by Elanco for the treatment and control of canine intestinal helminth infections. It contains the small-molecule antiparasitic agents praziquantel, pyrantel pamoate, and febantel in a beef-flavored chewable tablet formulation designed for dogs and puppies. The combination provides broad-spectrum activity against tapeworms, roundworms, hookworms, and whipworms, including *Dipylidium caninum*, *Taenia pisiformis*, *Echinococcus granulosus*, and *Echinococcus multilocularis*. Mechanistically, praziquantel disrupts cestode tegumental integrity and calcium homeostasis, pyrantel acts as a depolarizing nicotinic acetylcholine receptor agonist causing nematode spastic paralysis, and febantel is a probenzimidazole converted to active metabolites that inhibit parasite microtubule formation by binding beta-tubulin. The product is FDA-approved, prescription-only, indicated for dogs and puppies 3 weeks of age or older weighing at least 2 pounds, and is contraindicated in pregnant dogs.

Brand names
Drontal Plus TastyDrontal Plus Taste Tabs
Other names
praziquantel + pyrantel pamoate + febantel
02

Targets

Nicotinic Acetylcholine ReceptorCaV (Voltage-gated calcium channel protein complex)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on Drontal Plus Tasty.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drontal Plus Tasty.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call